Verdad Capital's research shows biotech stocks heavily owned by multiple specialist funds significantly outperform those with none. This "consensus" among experts acts as a powerful quality screen in a sector where traditional financial metrics are useless, as stocks with zero specialist ownership generate near-zero returns.

Analysis of Keynes's portfolio reveals a subtle skill: his true value-add came from ensuring his lowest-conviction ideas received minimal capital. Over his career, his bottom five positions shrank from 11.7% to just 6% of his portfolio, demonstrating a disciplined approach to managing risk on less-certain bets.

In a world of highly skilled money managers, absolute skill becomes table stakes and luck plays a larger role in outcomes. According to Michael Mauboussin's "paradox of skill," an allocator's job is to identify managers whose *relative* skill—a specific, durable edge—still dominates results.

The central task for capital allocators is to identify investment managers with a proven, durable edge—be it in sourcing, operations, or strategy—that allows them to consistently capture alpha in markets that are otherwise becoming more efficient.

In biotech investing, the collective wisdom of specialists is more valuable than any single expert's contrarian bet. Stocks owned by multiple specialists perform better, suggesting that an individual specialist's unique, high-alpha idea is more likely to be wrong than right.

A study in the book "Art of Execution" found the world's best investors have a win rate equivalent to a coin flip on their top 10 ideas. This proves superior returns come from how positions are managed after the initial buy decision, not from superior stock picking alone.

While managers can identify their best ideas within a larger portfolio, this doesn't mean a fund holding only those few ideas will succeed. Empirically, highly concentrated managers often don't outperform. This approach may attract managers whose success is more attributable to luck than skill.

Contrary to the belief that only a few mega-cap stocks drive market returns, a significant portion of S&P 500 companies—167 in the year of recording—outperform the index. This suggests that beating the market through stock picking is more attainable than commonly portrayed.

Analysis of New Zealand Super's performance revealed a mediocre "batting average" (hit rate of successful investments) but an amazing "slugging average." They succeeded by allocating disproportionately large amounts of risk to their highest-conviction ideas. The magnitude of wins, not their frequency, drives long-term outperformance.